Results 21 to 30 of about 2,397 (210)

Comparative Effectiveness of Torsemide Versus Furosemide in Heart Failure Patients: Insights From the Protect Trial [PDF]

open access: yesFuture Cardiology, 2015
The authors assessed the comparative effectiveness of torsemide versus furosemide in the PROTECT ...
Robert J Mentz   +2 more
exaly   +2 more sources

Structural basis for human NKCC1 inhibition by loop diuretic drugs [PDF]

open access: yesThe EMBO Journal
Na+–K+–Cl− cotransporters functions as an anion importers, regulating trans-epithelial chloride secretion, cell volume, and renal salt reabsorption. Loop diuretics, including furosemide, bumetanide, and torsemide, antagonize both NKCC1 and NKCC2, and are
Yongxiang Zhao   +6 more
doaj   +2 more sources

Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital.

open access: green, 2015
Furosemide has historically been the primary loop diuretic in heart failure patients despite data suggesting potential advantages with torsemide. We used the Duke Echocardiography Lab Database to investigate patients admitted with heart failure to Duke ...
Anstrom, Kevin J   +9 more
core   +3 more sources

Development and evaluation of a chronotherapeutic drug delivery system of torsemide [PDF]

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2011
The objective of this study was to prepare and evaluate chronotherapeutic drug delivery systems (ChrDDs) of torsemide. Compression coated tablets (CCT) containing torsemide in the core tablet were prepared by the compression coating technique with ...
Songa Ambedkar Sunil   +5 more
doaj   +2 more sources

TRANSFORM-HF Trial: Choice of loop diuretic in acute heart failure does not matter! [PDF]

open access: yesJournal of Family Medicine and Primary Care
The major clinical manifestations of heart failure (HF) are due to fluid retention and congestion, and thus, therapy targeting congestion plays a central role in HF management. Furosemide is by far the most commonly prescribed loop diuretic.
Akshyaya Pradhan   +2 more
doaj   +2 more sources

Mechanistic Differences between Torsemide and Furosemide. [PDF]

open access: yesJ Am Soc Nephrol
Key Points Oral torsemide was not superior to furosemide in measures of renal tubular delivery or duration of action.A dose equivalence of approximately 40 mg oral furosemide:10 mg oral torsemide resulted in similar natriuresis.The two-fold higher doses of torsemide did not improve fluid status
Rao VS   +19 more
europepmc   +3 more sources

Simple Spectrophotometric Determination of Torsemide in Bulk Drug and in Formulations [PDF]

open access: yesE-Journal of Chemistry, 2008
A simple and cost effective spectrophotometric method is described for the determination of torsemide in pure form and in pharmaceutical formulations.
Marothu Vamsi Krishna   +1 more
doaj   +2 more sources

Third Trimester Lower Extremity Lymphorrhea

open access: yesCase Reports in Obstetrics and Gynecology, 2021
Introduction. Lower extremity edema is one of the most common complaints among pregnant patients. However, there is no literature mentioning weeping edema (i.e., lymphorrhea) in a pregnant woman who has no concordant underlying renal and/or cardiac ...
Kaori Morimoto, Luke O’Rourke
doaj   +2 more sources

Photosensitive Lichenoid Reaction to Torsemide-a Loop Diuretic [PDF]

open access: bronzeMayo Clinic Proceedings, 1997
Torsemide, a potent loop diuretic of the sulfonylurea class, has been available for clinical use in the United States since 1993. Adverse generalized and cutaneous reactions to this medication are uncommon and are usually mild and transient. In this article, we describe an 82-year-old man who had a photosensitive lichenoid reaction due to torsemide ...
D R, Byrd, I, Ahmed
openaire   +3 more sources

BIOAVAILABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF TORSEMIDE IN PATIENTS WITH CIRRHOSIS

open access: yesClinical Pharmacology and Therapeutics, 1993
The bioavailability, pharmacokinetics, and pharmacodynamics of torsemide (10 mg orally and intravenously) were determined in a randomized crossover clinical trial with 12 patients with ascites caused by cirrhosis.
POUND, D   +5 more
core   +3 more sources

Home - About - Disclaimer - Privacy